Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CXCR4 | P61073 | 9/20 | 0.35 |
| ▸ | NPY1R | P25929 | 6/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4170089 | 0.95 | KDM1A (0.36) | KDM1AGAACXCR4NPY1RSLC6A4 | |
| SCHEMBL4181353 | 0.95 | KDM1A (0.36) | KDM1AGAACXCR4NPY1RSLC6A4 | |
| SCHEMBL5548255 | 0.95 | KDM1A (0.36) | KDM1AGAACXCR4NPY1RSLC6A4 | |
| SCHEMBL14566706 | 0.80 | KDM1A (0.42) | KDM1ACXCR4NPY1RSLC6A4KCNH2 | |
| SCHEMBL3083828 | 0.80 | KDM1A (0.42) | KDM1ACXCR4NPY1RSLC6A4KCNH2 | |
| SCHEMBL4068879 | 0.80 | KDM1A (0.42) | KDM1ACXCR4NPY1RSLC6A4KCNH2 | |
| SCHEMBL4887081 | 0.80 | KDM1A (0.42) | KDM1ACXCR4NPY1RSLC6A4KCNH2 | |
| SCHEMBL5547304 | 0.79 | MAPT (0.38) | GAANPY1RSLC6A4KCNH2ALDH1A1 | |
| SCHEMBL4173715 | 0.79 | MAPT (0.38) | GAANPY1RSLC6A4KCNH2ALDH1A1 | |
| SCHEMBL13875174 | 0.73 | HDAC1 (0.35) | CXCR4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090093454-A1 | Chemical Compounds | SMITHKLINE BEECHAM CORPORATION | 2009-04-09 | — | — | US | disclosed |
| US-20090093454-A1 | Chemical Compounds | SMITHKLINE BEECHAM CORPORATION | 2009-04-09 | — | — | US | disclosed |
| US-20090093454-A1 | Chemical Compounds | SMITHKLINE BEECHAM CORPORATION | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093454-A1 | Chemical Compounds | SLC10A1, CYP11B2, CYP4F3 | KDM1A 3659/4885GAA 466/4885CXCR4 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.